Typically, cancer cells appear to select against MPC expression33, because altered MPC1/MPC2 expression or activity may result in significant metabolic disorders and contribute to an increase in aerobic glycolysis in cancer cells (a.k.a., the Warburg effect)77, so that increased MPC activity may decrease cancer proliferation78. The gene discussed is MPC1; the disease is Other metabolic disease.